4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioLineRx Ltd. (BLRX) operates in the Biotechnology industry and is headquartered in Hevel Modi'in, Israel with about 20 employees. Its market capitalization is roughly ₪42 million. In the fiscal year ended 2025-12-31, BLRX reported $1M in revenue and ($1M) in net income.
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $1M | $29M | $5M | $0M |
| Gross Profit | $1M | $20M | $1M | $0M |
| Operating Income (EBIT) | ($10M) | ($19M) | ($43M) | ($29M) |
| Net Income | ($1M) | ($9M) | ($61M) | ($25M) |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($3M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($2M) | ($1M) | ($1M) | ($4M) | $5M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $41M | $39M | $64M | $76M | — |
| Total Liabilities | $18M | $25M | $51M | $26M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLRX viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms